Let’s be real: the tirzepatide price is the first thing most people search after hearing how effective the drug is. And it’s a fair concern. Medication that costs over $1,000 per month isn’t realistic for most people without a plan.
But here’s the thing — the list price is rarely what people actually pay. There are multiple ways to significantly reduce your cost, and this guide walks through all of them.
What Is Tirzepatide?
Tirzepatide is a weekly injectable medication approved by the FDA for:
- Type 2 diabetes — sold as Mounjaro (approved 2022)
- Chronic weight management — sold as Zepbound (approved 2023)
- Obstructive sleep apnea — Zepbound expanded indication (approved 2024)
Both versions contain the same active ingredient. Both are manufactured by Eli Lilly. The difference is the approved indication, which directly affects whether insurance will cover them.
To learn more about the treatment itself before looking at cost, visit the tirzepatide treatment overview from Tirzepatide Medics.
Tirzepatide Price Without Insurance
The list (retail) price for both brand-name versions is:
- Mounjaro: ~$1,079.77/month (28-day supply, 4 pens)
- Zepbound: ~$1,086.37/month (28-day supply, 4 pens)
Most people are not paying these prices. But understanding the baseline helps you evaluate what savings actually look like.
Tirzepatide Price With Insurance
Insurance coverage is one of the biggest variables. Here’s how it breaks down:
Mounjaro (Diabetes Indication)
Most commercial insurance plans cover Mounjaro when prescribed for type 2 diabetes. It typically requires:
- A diabetes diagnosis
- Prior authorization from your provider
- Documentation that other treatments were tried first
With commercial insurance and Eli Lilly’s savings card, eligible patients can pay as little as $25/month.
Zepbound (Weight Loss Indication)
Insurance coverage for Zepbound is harder to obtain. Many plans classify obesity medications as “lifestyle” drugs and exclude them.
However, some employer plans now cover Zepbound — coverage has expanded significantly in 2025. If approved, your copay could be as low as $25/month with the manufacturer’s savings card.
Medicare currently does NOT cover Zepbound for weight loss, though policy changes are expected in 2026.
Self-Pay Options: LillyDirect Program
For patients without qualifying insurance, Eli Lilly’s LillyDirect self-pay program offers Zepbound vials at reduced prices:
| Dose | Approximate Monthly Price |
|---|---|
| 2.5 mg | ~$299/month |
| 5 mg | ~$349/month |
| 7.5 mg | ~$499/month |
| 10 mg | ~$549/month |
| 12.5 mg | ~$549/month |
| 15 mg | ~$549/month |
Note: These prices require refilling within 45 days of the previous delivery. Missing that window increases the price.
Telehealth Programs: A More Accessible Route
Many patients access tirzepatide through telehealth providers who offer bundled programs including:
- Physician consultation
- Prescription management
- Medication delivery
- Ongoing follow-up
These programs typically range from $299–$499/month depending on dose and provider. They are often the fastest and most affordable pathway for patients who don’t qualify for insurance coverage.
At Tirzepatide Medics, programs are designed to keep treatment accessible. You can review all available pricing plans here and start with a consultation to find the right fit.
What About Compounded Tirzepatide?
Compounded tirzepatide was once widely available through telehealth pharmacies at prices around $300–$400/month. However, the FDA removed tirzepatide from the drug shortage list in October 2024, which effectively ended most compounding operations by March 2025.
Court rulings have upheld this decision. As of 2026, legitimate compounded tirzepatide is no longer available through standard telehealth channels.
Any provider currently offering “compounded tirzepatide” should be approached with significant caution.
Real Patient Cost Scenario: What People Actually Pay
Maria, 38, with commercial insurance (no diabetes diagnosis)
- Insurance denied Zepbound for weight loss
- Enrolled in the LillyDirect self-pay program
- Currently pays ~$349/month for 5 mg Zepbound
James, 52, with type 2 diabetes
- Insurance covers Mounjaro with prior authorization
- Uses the Mounjaro savings card
- Pays $25/month
Aisha, 45, no insurance
- Uses a telehealth program
- Pays $399/month, including consultation and medication
The difference between paying $25 and $1,086 is entirely about how you access the medication.
How to Lower Your Tirzepatide Price
- Check insurance coverage — call your plan directly and ask about Mounjaro or Zepbound coverage.
- Apply for the Lilly savings card — available at zepbound.lilly.com for eligible commercial insurance holders.
- Explore LillyDirect self-pay vials — starting at $299/month without insurance.
- Use a telehealth program — often the fastest option with transparent bundled pricing.
- Apply for patient assistance — Eli Lilly’s Lilly Cares Foundation offers free medication to low-income qualifying patients.
Does a Higher Dose Cost More?
With branded Zepbound pens (without insurance), all doses carry roughly the same list price. However, through LillyDirect’s self-pay program, lower doses are cheaper — starting at $299/month for 2.5 mg vs. $549/month for the higher doses.
This is actually an incentive to stay at your effective maintenance dose rather than escalating unnecessarily.
Is Tirzepatide Worth the Cost?
That’s a personal question, but the clinical data speaks clearly. In the SURMOUNT-1 trial, patients on tirzepatide lost an average of nearly 21% of their body weight over 72 weeks. For someone at 220 pounds, that’s roughly 46 pounds.
When weighed against the long-term health costs of obesity — cardiovascular disease, diabetes, sleep apnea, joint problems — the monthly investment in treatment often makes financial sense.
If you’re ready to talk through your options with a licensed provider, schedule a consultation today. Manage your ongoing care and track your progress in the patient portal.
Frequently Asked Questions
What is the tirzepatide price without insurance?
Brand-name Mounjaro and Zepbound both cost approximately $1,079–$1,086/month at list price without any savings programs applied.
Can I get tirzepatide for $25 a month?
Yes — if you have commercial insurance that covers tirzepatide and qualify for Eli Lilly’s savings card, you can pay as little as $25/month.
Does Medicare cover tirzepatide for weight loss?
No — Medicare currently does not cover Zepbound for weight loss, though coverage policy may expand in 2026 under proposed federal changes.
What is the cheapest way to get tirzepatide?
Commercial insurance with the Lilly savings card is the cheapest option; for uninsured patients, LillyDirect self-pay vials starting at $299/month are the most affordable brand-name route.
Is there a patient assistance program for tirzepatide?
Yes — Eli Lilly’s Lilly Cares Foundation may provide free medication to patients who meet income and eligibility requirements.
Does the tirzepatide price change by dose?
With pre-filled pens, the price is generally the same regardless of dose; with LillyDirect self-pay vials, lower doses cost less per month.
Sources
- FDA: Zepbound Official Prescribing Information
- Eli Lilly: Zepbound Cost & Coverage
- NIH/NLM: Tirzepatide Clinical Overview — StatPearls
- Medicaid.gov: State Coverage Information
